Table 1.

Clinical and demographic characteristics of the study population

Group	Age (Years)	Gender	BMI (kg/m2)	WHO stage	Viral load (copies/ml)	d4T as part of initial ART regimen	Duration of ART (months)
Control	N-A	M	N-A	N/A	N/A	N/A	N/A
Control	N-A	M	N-A	N/A	N/A	N/A	N/A
Control	N-A	M	N-A	N/A	N/A	N/A	N/A
Control	N-A	M	N-A	N/A	N/A	N/A	N/A
Control	N-A	M	N-A	N/A	N/A	N/A	N/A
HIV Neur	57	F	16.81	I	75	Yes	65
HIV Neur	42	M	23.31	I	<47	Yes	24
HIV Neur	50	M	20.67	II	452	Yes	12
HIV Neur	61	M	18.58	I	<47	Yes	32
HIV Neur	56	F	19.38	II	521	Yes	4
HIV Neur	47	M	30.06	IV	4299	N-A	N-A
HIV Neur	55	M	30.10	I	148	Yes	65
HIV Neur	40	F	24.84	IV	N-A	Yes	65
HIV/HTLV Neur	40	F	22.83	I	<47	Yes	51
HIV/HTLV Neur	36	M	17.08	I	1051596	Yes	36
HIV/HTLV Neur	35	F	17.10	II	49	Yes	23
HIV/HTLV Neur	39	F	21.80	I	73347	N/A	0
HIV/HTLV Neur	37	F	24.92	I	1407	Yes	61
HIV/HTLV Neur	50	F	17.40	I	114	Yes	63
HIV/HTLV Neur	50	M	25.18	I	<47		12
HIV/HTLV Neur	50	F	33.59	I	N-A	N/A	0

HIV Neur HIV infected with neurological symptoms, HIV/HTLV Neur HIV and HITLV co-infected with neurological symptoms, BMI Body mass index, M/F male/female, N/A not applicable, N-A Not available